GW Pharmaceuticals plc appointed Catherine Mackey, Alicia Secor and William Waldegrave as independent board members.
Mackey is the CEO of CYPrus Therapeutics Inc. and board chairman of Cour Pharmaceutical Development. Secor is the president and CEO of Juniper Pharmaceuticals Inc., while Waldegrave served as chairman of Biotechnology Growth Trust plc from 1998 to 2015.
